Aberrant astrocyte protein secretion contributes to altered neuronal development in multiple models of neurodevelopmental disorders
Top Cited Papers
- 30 August 2022
- journal article
- research article
- Published by Springer Nature in Nature Neuroscience
- Vol. 25 (9) , 1163-1178
Abstract
Astrocytes negatively impact neuronal development in many models of neurodevelopmental disorders (NDs); however, how they do this, and if mechanisms are shared across disorders, is not known. In this study, we developed a cell culture system to ask how astrocyte protein secretion and gene expression change in three mouse models of genetic NDs (Rett, Fragile X and Down syndromes). ND astrocytes increase release of Igfbp2, a secreted inhibitor of insulin-like growth factor (IGF). IGF rescues neuronal deficits in many NDs, and we found that blocking Igfbp2 partially rescues inhibitory effects of Rett syndrome astrocytes, suggesting that increased astrocyte Igfbp2 contributes to decreased IGF signaling in NDs. We identified that increased BMP signaling is upstream of protein secretion changes, including Igfbp2, and blocking BMP signaling in Fragile X and Rett syndrome astrocytes reverses inhibitory effects on neurite outgrowth. This work provides a resource of astrocyte-secreted proteins in health and ND models and identifies novel targets for intervention in diverse NDs.Keywords
All Related Versions
Funding Information
- Mary K. Chapman Foundation
- Autism Speaks (10640)
- U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (F30 HD106699)
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (NIH-NCI CCSG: P30 014195, NIH-NCI CCSG: P30 014195)
- Leona M. and Harry B. Helmsley Charitable Trust
- U.S. Department of Health & Human Services | NIH | National Cancer Institute
- Hearst Foundations
- Pew Charitable Trusts
- Chan Zuckerberg Initiative Salk Institute Innovation Grant
This publication has 74 references indexed in Scilit:
- Identification of the translocation breakpoints in the Ts65Dn and Ts1Cje mouse lines: relevance for modeling down syndromeMammalian Genome, 2011
- Development of a Method for the Purification and Culture of Rodent AstrocytesNeuron, 2011
- A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem CellsCell, 2010
- Evidence of reactive astrocytes but not peripheral immune system activation in a mouse model of Fragile X syndromeBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2010
- A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regionsHuman Molecular Genetics, 2010
- MeCP2 deficiency disrupts axonal guidance, fasciculation, and targeting by altering Semaphorin 3F functionMolecular and Cellular Neuroscience, 2009
- Carboxypeptidase E knockout mice exhibit abnormal dendritic arborization and spine morphology in central nervous system neuronsJournal of Neuroscience Research, 2009
- Non–cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphologyNature Neuroscience, 2009
- Dementia in fragile X‐associated tremor/ataxia syndrome (FXTAS): Comparison with Alzheimer's diseaseAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2008
- Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue.Journal of Cell Biology, 1980